DrugDev Acquires Award-Winning Trialnetworks Platform, Launches Innovation Lab, Unveils Investigator Databank Website And Reaches $1 Billion In Global Site Payments In First Half Of 2014

LONDON & AUDUBON, Pa.--(BUSINESS WIRE)--DrugDev, an innovative provider of technology-driven solutions and the industry’s largest network of active global investigators, accomplished several major milestones throughout the first half of 2014.

The company acquired CFS Clinical toward the end of 2013 and customers realized immediate benefits in Q1 of this year by integrating the industry leading site payment solution and site contracting services with DrugDev’s established site selection services.

In May, DrugDev acquired Newton, Mass.-based TrialNetworks, which provides a unified cloud-based platform of trial management apps and site-facing tools that was awarded Disruptive Technology of the Year by Partnerships in Clinical Trials 2014. Following the acquisition, TrialNetworks and DrugDev hosted a collaborative annual Summit for clinical operations leaders in Boston – featuring a keynote from Dr. Jorge Guerra and case study presentations from customers – to share best practices, site engagement strategies and creative solutions to challenges facing the industry.

Help employers find you! Check out all the jobs and post your resume.